Literature DB >> 19296076

Thiamine in diabetic nephropathy: a novel treatment modality?

A Alkhalaf, N Kleefstra, K H Groenier, S J L Bakker, G J Navis, H J G Bilo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19296076     DOI： 10.1007/s00125-009-1326-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  1 in total

1.  High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study.

Authors:  N Rabbani; S S Alam; S Riaz; J R Larkin; M W Akhtar; T Shafi; P J Thornalley
Journal:  Diabetologia       Date:  2008-12-05       Impact factor: 10.122
  1 in total
  2 in total

1.  Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes.

Authors:  N Karachalias; R Babaei-Jadidi; N Rabbani; P J Thornalley
Journal:  Diabetologia       Date:  2010-04-06       Impact factor: 10.122

2.  A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy.

Authors:  Alaa Alkhalaf; Astrid Klooster; Willem van Oeveren; Ulrike Achenbach; Nanne Kleefstra; Robbert J Slingerland; G Sophie Mijnhout; Henk J G Bilo; Reinold O B Gans; Gerjan J Navis; Stephan J L Bakker
Journal:  Diabetes Care       Date:  2010-04-22       Impact factor: 17.152
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.